Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01058070 · ClinicalTrials.gov registry record · NA
An Observational Clinical Feasibility Study of the Magnetic Esophageal Sphincter
A NA study, sponsored by Torax Medical Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01058070 is a NA study that has completed, run by Torax Medical Incorporated. The registered enrollment target is 44 participants.
The verdict
NCT01058070, a NA study, has completed, sponsored by Torax Medical Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
Magnetic Esophageal Sphincter implant is intended to reinforce Esophageal Sphincter function in the treatment of Gastroesophageal Reflux Disease (GERD)
Interventions
- DEVICE Torax Medical, Inc. LINX Reflux Management System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2007-02 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01058070
The ClinicalTrials.gov registry entry for NCT01058070 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Torax Medical Incorporated, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Torax Medical, Inc. LINX Reflux Management System is the first listed.
NCT01058070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01058070 about?
NCT01058070 is a clinical study titled "An Observational Clinical Feasibility Study of the Magnetic Esophageal Sphincter". Magnetic Esophageal Sphincter implant is intended to reinforce Esophageal Sphincter function in the treatment of Gastroesophageal Reflux Disease (GERD)
What is the current status of trial NCT01058070?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2007-02. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01058070?
The interventions under investigation include: Torax Medical, Inc. LINX Reflux Management System (DEVICE).
Who is sponsoring clinical trial NCT01058070?
This trial is sponsored by Torax Medical Incorporated, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.